Advertisement
Advertisement
Trending on Psychiatric Times
1
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia
2
Cobenfy for Treatment of Schizophrenia Now Approved in China
3
Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics
4
Latest Alzheimer Disease Data: Reports from CTAD 2025
5